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Background: Endothelial dysfunction is linked to exaggerated production of super-
oxide anions. This study was conducted to examine the effects of oxidative stress on
endothelial modulation of contractions in chronic two-kidney, one-clip (2K1C) renal
hypertensive rats.
Methods: The 2K1C hypertension was induced by clipping the left renal artery;
age-matched rats receiving sham treatment served as controls. Thoracic aortae were
isolated and mounted in tissue baths for measurement of isometric tension.
Results: Norepinephrine-induced contraction was augmented by the removal of the
endothelium, which was more pronounced in sham rats than in 2K1C rats. Nω-nitro-
L-arginine methyl ester, an inhibitor of nitric oxide production, had a similar augment-
ing effect. Vitamin C inhibited the contraction in aortic rings with intact endothelium
from 2K1C rats but not from sham rats. The contraction was also suppressed by
treatment with diphenyleneiodonium or apocynin, inhibitors of nicotinamide adenine
dinucleotide/nicotinamide adenine dinucleotide phosphate (NADH/NADPH) oxidase, in
the aortae with intact endothelium from 2K1C rats but not in those from sham rats.
Superoxide anions generated by xanthine oxidase/hypoxanthine enhanced the contrac-
tion in the aortae with intact endothelium from sham rats, but had no effect in 2K1C
rats. Enhanced contractile responses to norepinephrine by xanthine oxidase/hypox-
anthine in sham rats were reversed by vitamin C.
Conclusion: These results suggest that the effect on endothelial modulation of
endothelium-derived nitric oxide is impaired in 2K1C hypertension. The impairment
is, at least in part, related to increased production of superoxide anions by NADH/
NADPH oxidase.
& 2014. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).n Society of Nephrology. Publi
c-nd/4.0/).
logy, College of Medicine,
, Gwangju 501-759,
).Introduction
Initially regarded as an inert lining between blood and blood
vessels, the vascular endothelium has a critical role in the
maintenance of vascular tone and blood pressure by generating
various vasoactive substances [1]. In physiological states, the
endothelium releases both relaxing and contracting factors;shed by Elsevier. This is an open access article under the CC BY-NC-ND
Kidney Res Clin Pract 33 (2014) 19–2520a balance between these two factors contributes to the local
regulation of vascular tone [2]. It has been known that hyper-
tension is characterized by endothelial dysfunction in large
conduit and small resistance arteries [3,4]. Endothelium-
dependent vasodilation is indeed impaired in a number of
experimental models, including two-kidney, one-clip (2K1C)
hypertension [5–7]. Reduced production of endothelial relax-
ing factors or increased production of endothelial contractile
substances may be responsible for the depressed endothelium-
dependent relaxation in hypertension [8].
In addition to the direct relaxing or contracting effects of
the endothelium, it can also modulate the effects of vasocon-
strictor substances. The important role of the vascular endo-
thelium in the response of isolated vascular segments to
several vasoconstrictors, including norepinephrine, is widely
recognized [6,9]. Constrictors apparently interact with the
endothelium and induce the release of relaxing factors, which
then have an inhibitory effect on vascular smooth muscle
tone [6,10]. In our previous study, we demonstrated that
the endothelium plays an inhibitory role against contractile
responses to norepinephrine by releasing nitric oxide (NO),
and the endothelial inhibition is attenuated in 2K1C hyperten-
sion [11]. Nevertheless, the mechanisms underlying the
impaired endothelial modulation in hypertension remain to
be established.
An endothelial dysfunction is known to be linked to the
exaggerated production of superoxide anions. It has been
proposed that increased oxidative inactivation of NO caused
by an excess of superoxide anions is responsible for reducing
the bioavailability of NO, which is in part related to endothelial
dysfunction in hypertension [12,13]. Miyagawa et al [14]
reported that vascular oxidative stress could contribute to an
altered circulation by impairment of endothelial modulation of
vascular contractions in spontaneously hypertensive rats. In
addition, an increase in oxidative stress systemically plays a
major role in the maintenance of high arterial blood pressure
and sympathetic drive in renal hypertension [15]. We also
observed that hydrogen peroxide may contribute in part to the
altered vascular relaxation in 2K1C hypertensive rats [16].
The current study was undertaken to determine whether
oxidative stress is involved in the impaired endothelial mod-
ulation of vascular contractions in 2K1C renal hypertension.Methods
Induction of 2K1C renal hypertension
Male Sprague-Dawley rats (160–180 g) were anesthetized
with sodium thiopental (40 mg/kg, IP). The left posterior side
of the animal was shaved and sterilized with 70% ethanol. An
incision of approximately 2 cm in length was made through
the skin and muscles just below the ribs. The left kidney was
then exposed and retracted in order to expose the renal artery,
and a silver clip (internal diameter 0.2 mm) was applied to the
exposed renal artery. The clip was then turned such that the
slit opening was facing the abdomen. The contralateral kidney
was left intact. The muscles and skin were then sutured, and
the animal was left to recover from anesthesia. Control rats
received a sham treatment, which involved exactly the same
procedure except that no clip was placed. Postoperatively, all
animals were fed normal chow and given tap water. They were
operated at 10 weeks after clipping, because endothelialdysfunction is associated with the duration of hypertension
[17]. Hypertensive rats were selected based on systolic blood
pressure measured in a conscious state using the tail-cuff
method and a piezoelectric pneumotaxic pulse transducer.
Tissue preparation
The thoracic aorta between the aortic arch and diaphragm
was removed rapidly and placed in a physiological salt solution
of the following composition: NaCl 118.3mM, KCl 4.7mM,
NaHCO3 25mM, MgCl2 1.2mM, KH2PO4 1.2mM, CaCl2 2.5mM,
and glucose 11.1mM. Vessels were cleaned of adhering tissue
and cut into rings (2 mmwide) under a dissection microscope.
Care was taken not to stretch the artery or damage the luminal
surface. In some preparations, the endothelium was removed
by gentle rubbing of the intimal surface with a moist cotton
swab. Successful removal of endothelial cells from aortic
rings was conﬁrmed by the inability of acetylcholine to induce
relaxation.
The aortic rings were suspended using two triangular-
shaped stainless-steel holders in the vessel lumen in organ
chambers containing 15 mL of physiological salt solution main-
tained at 371C and aerated with 95% O2 and 5% CO2. To measure
isometric tension development, one of the holders was ﬁxed at
the bottom of the chambers and the other was connected to a
force displacement transducer (FTO3; Grass Technologies, War-
wick, RI, USA). Prior to initiating speciﬁc experimental proto-
cols, aortic rings were stretched to the point of their optimal
length–tension relationship, which was determined to be 2 g by
similar preliminary experiments involving repeated exposure to
60mM KCl solution (obtained by equimolar replacement of NaCl
by KCl in physiological solution), and allowed to equilibrate for
90 minutes. After equilibration, rings were maximally con-
tracted by the 60mM KCl solution to test their contractile
capacity.
Protocols
During the ﬁrst set of experiments, contractile responses
to norepinephrine (1010–105M) were determined in rings
with or without the endothelium. To obtain α-adrenoceptor-
mediated responses to norepinephrine, aortic rings were pre-
treated with a β-adrenoceptor antagonist timolol (3107M). To
conﬁrm the role of NO in the endothelium-dependent modulation
of vascular contraction, concentration–response curves of norepi-
nephrine were obtained in the presence of Nω-nitro-L-arginine
methyl ester (L-NAME; 104M), which inhibits the endogenous
production of NO from L-arginine.
In the second set of experiments, to verify the role of
oxidative stress and the involvement of nicotinamide adenine
dinucleotide/nicotinamide adenine dinucleotide phosphate
(NADH/NADPH) oxidase in endothelial dysfunction in 2K1C
rats, effects of vitamin C (104M) or inhibitors of NADH/NADPH
oxidase, diphenyleneiodonium (DPI; 105M), or apocynin
(3105M) on the contractile responses to norepinephrine
[14] were determined. In order to assess the potential role of
other enzymatic sources of superoxide anions, we recorded
the concentration–response to norepinephrine of aortic rings
pretreated with allopurinol (3 104M), a xanthine oxidase
inhibitor.
In the third set of experiments, using the hypoxanthine–
xanthine oxidase system, which generates superoxide anions
and hydrogen peroxides [18], we examined the effects of
5678910
C
l) 120
140
160
Te
ns
io
n 
(%
 o
f 6
0m
M
 K
C
l)
0
20
40
60
80
100
120
Choi et al / Oxidative stress in renal hypertension 21superoxide anions on the contractile response to norepinephr-
ine. Concentration–response curves of norepinephrine in the
absence or presence of hypoxanthine (2 104M)/xanthine
oxidase (20 U/L) plus catalase (1,000 U/mL) were plotted.
Drugs
The drugs used in this study were acetylcholine chloride,
apocynin (Calbiochem, Los Angeles, CA, USA), catalase, DPI,
hypoxanthine, L-norepinephrine bitartrate, L-NAME, timolol
maleate, vitamin C (L-ascorbic acid), and xanthine oxidase.
They were purchased from Sigma Chemical Co. (St Louis, MO,
USA) unless otherwise stated. All drugs were administered in
volumes not exceeding 0.5% of the bath volume.
Statistical analysis
Contractile responses are percentages of contractions eli-
cited by 60mM KCl. Values presented in the ﬁgures are means
and standard errors of the means, and the numbers of aortic
rings tested are provided in parentheses. Statistical compar-
isons were performed using the unpaired t test or analysis of
variance with repeated measurements and Fischer’s post hoc
test. Differences were considered signiﬁcant for Po0.05.Norepinephrine (-log M)
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Figure 1. Concentration–response curves of norepinephrine in aor-
tic rings with (þ) or without () endothelium from sham-operated
(A) and 2K1C hypertensive (B) rats. Results obtained from rings with
endothelium in the presence of L-NAME (104M) are also shown.
Results are representative of six to eight experiments.
n, † Po0.05, compared with corresponding þEndo values.
Endo, endothelium; L-NAME, Nω-nitro-L-arginine methyl ester; 2K1C,
two-kidney, one clip.Results
Ten weeks after surgery, the systolic blood pressure was
13673 mmHg (n¼38) and 19074 mmHg (n¼40) in sham-
clipped control and 2K1C hypertensive rats, respectively
(Po0.05). The magnitude of KCl (60mM)-induced isometric
tension development was comparable in the two groups (1.417
0.10 g in control and 1.4970.13 g in 2K1C rats).
In aortic rings from sham-clipped control and 2K1C rats,
norepinephrine induced contraction in a concentration-
dependent manner. The contractile response to norepinephr-
ine was augmented in 2K1C rats compared to that in
sham rats. Norepinephrine-induced contraction was enhanced
by the removal of the endothelium in sham rats, but not in
2K1C rats. L-NAME treatment had an effect similar to that of
endothelium removal (Fig. 1).
To determine whether the impaired endothelial inhibition
of norepinephrine-induced contraction is related to oxidative
stress, effects of vitamin C on norepinephrine-induced con-
traction were examined in aortic rings with intact endo-
thelium. Vitamin C inhibited the contractile response to
norepinephrine in 2K1C rats but not in sham controls (Fig. 2).
To conﬁrm the origin of oxidative stress, the effects of DPI
or apocynin on norepinephrine-induced contraction were
examined. DPI attenuated the contractile response to norepi-
nephrine in the aortic rings from 2K1C rats, but not in sham
rats (Fig. 3). Norepinephrine-induced contraction was also
attenuated by pretreating aortic rings with apocynin in 2K1C
rats but not in controls (Fig. 4).
By contrast, allopurinol, a xanthine oxidase inhibitor,
affected the contractile response to norepinephrine neither
in 2K1C rats nor in sham rats (data not shown).
Norepinephrine-induced contraction was enhanced by treat-
ment with xanthine oxidase in the presence of hypoxanthine in
aortic rings from sham rats, which was abolished by vitamin C.
However, the hypoxanthine–xanthine oxidase system had noeffect on the contractile response to norepinephrine in 2K1C
rats (Fig. 5).Discussion
The vascular response to norepinephrine was enhanced in
2K1C hypertension, as was in our previous studies [10,11]. The
augmented contraction in hypertension has been attributed
to augmented phosphoinositide hydrolysis, greater release of
intracellular Ca2þ from a cellular pool, increased activation
of protein kinase C, or alterations in the number and afﬁnity of
inositol trisphosphate receptors on the endoplasmic reticulum
of vascular smooth muscle [19]. Many of these processes may
also be responsible for the increased sensitivity of vascular
response to norepinephrine in 2K1C hypertension.
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Figure 3. Effects of DPI on concentration–response to norepinephr-
ine in aortic rings with endothelium from sham-operated (A) and
2K1C hypertensive (B) rats. Results are representative of six to eight
experiments.
n Po0.05, compared with corresponding control values.
DPI, diphenyleneiodonium; 2K1C, two-kidney, one clip.
Norepinephrine (-log M)
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Figure 2. Effects of vitamin C on concentration–response to norepi-
nephrine in aortic rings with endothelium from sham-operated
(A) and 2K1C hypertensive (B) rats. Results are representative of six
to eight experiments.
n Po0.05, compared with corresponding control values.
2K1C, two-kidney, one clip.
Kidney Res Clin Pract 33 (2014) 19–2522In the present study, endothelium removal and L-NAME
treatment had similar effects on norepinephrine-induced
contraction, which suggest that NO plays a critical role in
endothelial modulation of norepinephrine-induced contrac-
tion. As was found in our previous study [11], the inhibitory
effect of the endothelium on the norepinephrine-induced
contraction was also attenuated in 2K1C rats in the present
study. The endothelial dysfunction may be an impaired relaxa-
tion or an exaggerated contractile response. In 2K1C hyper-
tensive rats, the impaired endothelial modulation of vascular
contractions induced by norepinephrine may be related to a
decreased production of NO, an increase in inactivation of NO,
and/or altered NO-cyclic guanosine monophosphate (cGMP)
signaling. We previously showed that relaxations induced by
sodium nitroprusside are similar in aortic rings from 2K1C and
sham control rats [11]. Based on the abovementioned ﬁndings,
NO-cGMP signaling appears to be preserved in 2K1Chypertension. In addition, Miyagawa et al [14] demonstrated
that NO levels were not altered, but rather the function of the
endothelium was impaired. We also previously found that
plasma concentrations of NO were comparable between 2K1C
and sham rats [20]. Thus, it appears that the production of NO
is not altered in hypertension, but its inactivation is enhanced.
Previous studies have demonstrated that the production of
superoxide anions by the vascular wall is enhanced in various
models of hypertension, including 2K1C rats [14,15,21,22]. In
the present study, contractile responses to norepinephrine
were inhibited signiﬁcantly by pretreatment with vitamin C,
an antioxidant, in the aortic rings from 2K1C rats, but not
in those from sham control rats. It has been reported that
impaired endothelium-dependent relaxation induced by acet-
ylcholine in hypertension is improved by vitamin C, which
acts as a free radical scavenger [23]. Therefore, the production
of reactive oxygen species may play a role in the impaired
Norepinephrine (-log M)
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Figure 4. Effects of apocynin on concentration–response to norepi-
nephrine in aortic rings with endothelium from sham-operated
(A) and 2K1C hypertensive (B) rats. Results are representative of six
to eight experiments.
n Po0.05, compared with corresponding control values.
2K1C, two-kidney, one clip.
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Figure 5. Effects of HXþXO and HXþXOþVit. C in the presence of
catalase on concentration–response to norepinephrine in aortic
rings with endothelium from sham-operated (A) and 2K1C hyper-
tensive (B) rats. Results are representative of six to eight experiments.
n Po0.05, compared with corresponding control values.
† Po0.05, compared with corresponding HX þ XO values.
HX, hypoxanthine; Vit. C, vitamin C; XO, xanthine oxidase; 2K1C, two-
kidney, one clip.
Choi et al / Oxidative stress in renal hypertension 23endothelial modulation of vascular contractions in 2K1C hyper-
tension, although vitamin C could either increase endothelial
NO synthase (eNOS) activity or reduce the production of
superoxide anions by inhibiting NADH/NADPH oxidase [24].
An enhanced production of superoxide anions may result in
inactivation of NO and generation of peroxynitrite [15]. The
resulting decrease in availability of NO may have a role in the
impaired endothelial modulation of arterial contractions.
Superoxide anions have several possible sources, including
NADH/NADPH oxidase, eNOS, and xanthine oxidase. It has
been suggested that the generation of superoxide anions
within the vascular wall is responsible for NADH/NADPH
oxidase [14], and its involvement in the production of super-
oxide anions in the arteries from 2K1C hypertensive rats
has also been reported [22]. As expected, DPI, a NADH/NADPH
oxidase inhibitor, attenuated the norepinephrine-induced
contraction in aortic rings from 2K1C rats but had no effect
in those from sham rats in the present study. These results
indicate that the production of superoxide anions in hypertensivevascular tissue is related to a NADH/NADPH oxidase-dependent
mechanism in norepinephrine-induced contractions. Furthermore,
another speciﬁc inhibitor of NADH/NADPH oxidase [14],
apocynin, which is an endothelium-dependent as well as
endothelium-independent relaxant [25], also reversed the
impaired endothelial modulation in 2K1C rats. Therefore,
NADH/NADPH oxidase appears to be the most plausible source
of excessive production of superoxide anions in 2K1C hyper-
tension, although DPI may also inhibit eNOS. To our knowl-
edge, this is the ﬁrst study showing that the source of
superoxide production for the impaired endothelial modula-
tion in chronic renal hypertension.
By contrast, allopurinol, a xanthine oxidase inhibitor, did
not affect norepinephrine-induced contraction in either sham
or 2K1C rats, as has been previously shown in genetically
hypertensive rats [14]. In addition, nitrite has been reported
to exert antihypertensive effects in 2K1C hypertensive rats,
which may be related to its antioxidant properties resulting
Kidney Res Clin Pract 33 (2014) 19–2524from the inhibition of vascular NADPH oxidase activity but not
from the inhibition of xanthine oxidase activity [26]. There-
fore, xanthine oxidase is unlikely to be involved in the
production of superoxide anions under the experimental
conditions of this study.
Renovascular hypertension caused by renal artery stenosis
stimulates the renin–angiotensin system, thereby elevating
circulating angiotensin II (Ang II) levels. However, despite the
fact that the 2K1C model has been investigated extensively,
the exact mechanisms responsible for the maintenance of
hypertension in this model remain unclear. One hypothesis is
that an increase in Ang II can activate NADH/NADPH oxidase
and produce superoxide anions, thus decreasing the bioavail-
ability of NO and increasing vasoconstriction, in addition to
increasing the sympathetic activity [15]. Ang II has been
shown to stimulate the generation of superoxide anion radi-
cals in cultured vascular smooth muscle cells [27]. Further-
more, the expression of NADH/NADPH oxidase has been
reported to be upregulated in 2K1C hypertension [15]. Taken
together, it cannot be ruled out that Ang II may affect the
production of superoxide anions in 2K1C hypertension,
although we did not determine the concentration of Ang II.
Oxidant stress conditions can be created in isolated aortic
rings by the generation of superoxide anions via the hypox-
anthine–xanthine oxidase system [28]. However, these condi-
tions are complicated by the fact that superoxide-generating
systems also increase other reactive oxygen species such as
hydrogen peroxide, hydroxyl radicals, and peroxynitrite, which
can damage the endothelium and impair endothelial modulation
[29]. We wished to examine speciﬁcally the interaction between
NO and superoxide anions. Therefore, catalase was included in
our experiment [14]. In the present study, the hypoxanthine–
xanthine oxidase system enhanced the norepinephrine-induced
contraction in aortic rings from sham-clipped rats in the pre-
sence of catalase. The augmented contractile response to nor-
epinephrine in controls was abolished by the addition of vitamin
C, suggesting that the observed impaired endothelial modulation
of vascular contractions is due to increased superoxide anions. In
2K1C rats, however, norepinephrine-induced contractionwas not
altered by treatment with the hypoxanthine–xanthine oxidase
system. The possible explanations for these observations may
be that the released NO is inactivated mostly by endogenous
superoxide anions derived from NADH/NADPH oxidase in hyper-
tensive vascular tissues, and that the additional inhibitory effects
against NO may not have been evoked by the generation of
exogenous superoxide anions.
In summary, endothelial modulation of vascular contrac-
tions is impaired in the aortae of 2K1C hypertensive rats. The
impairment may, at least in part, be due to an increased
production of superoxide anions by NADH/NADPH oxidase.
Vascular oxidative stress may be involved in the endothelial
dysfunction in chronic 2K1C renal hypertension.Conﬂicts of interest
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